Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The phase II study evaluate a light dose escalation in a classical intraoperative PDT regimen
mediated by 5-ALA-PpIX, in glioblastoma patients with access to full surgical removal of the
contrast enhancement. This treatment will be performed in addition to the current reference
treatment of glioblastoma: maximum removal surgery followed by radiochemotherapy according to
the Stupp protocol.